| Yue Zhang, MD | |
|
1950 Glenn Mitchell Dr Ste 102, Virginia Beach, VA 23456-0019 | |
| (757) 368-0437 | |
| (757) 368-0492 |
| Full Name | Yue Zhang |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 20 Years |
| Location | 1950 Glenn Mitchell Dr Ste 102, Virginia Beach, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881906311 | NPI | - | NPPES |
| 1881906311 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 275430 (New York) | Secondary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | 0101269777 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Leigh Hospital | Norfolk, VA | Hospital |
| Sentara Princess Anne Hospital | Virginia beach, VA | Hospital |
| Sentara Virginia Beach General Hospital | Virginia beach, VA | Hospital |
| Sentara Norfolk General Hospital | Norfolk, VA | Hospital |
| Sentara Obici Hospital | Suffolk, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virginia Oncology Associates | 2769395797 | 101 |
News Archive
Researchers from Taiwan report in a new study that unsedated colonoscopy for primary colorectal cancer screening is well accepted in a majority of patients. Sedation is typically used for colonoscopy to make the patient feel comfortable during the procedure.
A virus not known to cause disease kills triple-negative breast cancer cells and killed tumors grown from these cells in mice, according to Penn State College of Medicine researchers. Understanding how the virus kills cancer may lead to new treatments for breast cancer.
Boston Scientific Corporation today announced U.S. Food and Drug Administration (FDA) approval for LATITUDE 6.0, a software upgrade to the Company's LATITUDE® Patient Management system. The LATITUDE system enables physicians to remotely monitor patients with implantable cardiac devices. The upgrade provides enhanced functionality, including the ability to view an expanded history of a patient's remote follow-up data.
Cortex Pharmaceuticals, Inc. reported a net loss of approximately $1,175,000, or $0.01 per share, for the quarter ended September 30, 2011, compared with a net loss of approximately $528,000, or $0.01 per share, for the corresponding prior year quarter.
Teagasc will coordinate a major new €1.3 million national research project, titled 'National Cheese Research Programme 2015'. Dr Phil Kelly, coordinator of the project, said: "The Irish Cheese Research Consortium (ICRC) embraces the Irish dairy industry's forecast for significant expansion in cheese production, both in overall volume and in specific varieties, over the next 10 years."
› Verified 2 days ago
| Entity Name | Virginia Oncology Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417929639 PECOS PAC ID: 2769395797 Enrollment ID: O20031106000522 |
News Archive
Researchers from Taiwan report in a new study that unsedated colonoscopy for primary colorectal cancer screening is well accepted in a majority of patients. Sedation is typically used for colonoscopy to make the patient feel comfortable during the procedure.
A virus not known to cause disease kills triple-negative breast cancer cells and killed tumors grown from these cells in mice, according to Penn State College of Medicine researchers. Understanding how the virus kills cancer may lead to new treatments for breast cancer.
Boston Scientific Corporation today announced U.S. Food and Drug Administration (FDA) approval for LATITUDE 6.0, a software upgrade to the Company's LATITUDE® Patient Management system. The LATITUDE system enables physicians to remotely monitor patients with implantable cardiac devices. The upgrade provides enhanced functionality, including the ability to view an expanded history of a patient's remote follow-up data.
Cortex Pharmaceuticals, Inc. reported a net loss of approximately $1,175,000, or $0.01 per share, for the quarter ended September 30, 2011, compared with a net loss of approximately $528,000, or $0.01 per share, for the corresponding prior year quarter.
Teagasc will coordinate a major new €1.3 million national research project, titled 'National Cheese Research Programme 2015'. Dr Phil Kelly, coordinator of the project, said: "The Irish Cheese Research Consortium (ICRC) embraces the Irish dairy industry's forecast for significant expansion in cheese production, both in overall volume and in specific varieties, over the next 10 years."
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yue Zhang, MD 6350 Center Dr, Ste 200, Norfolk, VA 23502-4107 Ph: (757) 213-5700 | Yue Zhang, MD 1950 Glenn Mitchell Dr Ste 102, Virginia Beach, VA 23456-0019 Ph: (757) 368-0437 |
News Archive
Researchers from Taiwan report in a new study that unsedated colonoscopy for primary colorectal cancer screening is well accepted in a majority of patients. Sedation is typically used for colonoscopy to make the patient feel comfortable during the procedure.
A virus not known to cause disease kills triple-negative breast cancer cells and killed tumors grown from these cells in mice, according to Penn State College of Medicine researchers. Understanding how the virus kills cancer may lead to new treatments for breast cancer.
Boston Scientific Corporation today announced U.S. Food and Drug Administration (FDA) approval for LATITUDE 6.0, a software upgrade to the Company's LATITUDE® Patient Management system. The LATITUDE system enables physicians to remotely monitor patients with implantable cardiac devices. The upgrade provides enhanced functionality, including the ability to view an expanded history of a patient's remote follow-up data.
Cortex Pharmaceuticals, Inc. reported a net loss of approximately $1,175,000, or $0.01 per share, for the quarter ended September 30, 2011, compared with a net loss of approximately $528,000, or $0.01 per share, for the corresponding prior year quarter.
Teagasc will coordinate a major new €1.3 million national research project, titled 'National Cheese Research Programme 2015'. Dr Phil Kelly, coordinator of the project, said: "The Irish Cheese Research Consortium (ICRC) embraces the Irish dairy industry's forecast for significant expansion in cheese production, both in overall volume and in specific varieties, over the next 10 years."
› Verified 2 days ago
Haidr Agha, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1157 First Colonial Rd, Ste 200, Virginia Beach, VA 23454 Phone: 757-623-0005 Fax: 757-389-5383 | |
Howard Courtenay Harrison Sr., MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1101 First Colonial Rd, Suite 101, Virginia Beach, VA 23454 Phone: 757-496-9020 Fax: 757-481-0638 | |
Vincent Lee, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 5516 Virginia Beach Blvd, Virginia Beach, VA 23462 Phone: 757-473-3969 | |
Dr. Sue Beth Hudson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 802 Newtown Rd, Virginia Beach, VA 23462 Phone: 757-497-0606 Fax: 757-497-0411 | |
Dr. Rosario Devera Hipol, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 701 Independence Cir Ste 102, Virginia Beach, VA 23455 Phone: 757-499-6395 Fax: 757-499-8026 | |
Dr. Jonah Anyaogu Ulu Ezieme, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1060 First Colonial Rd, Virginia Beach, VA 23454 Phone: 757-395-2323 Fax: 757-827-2255 | |
Dr. James Richard Miller, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1101 First Colonial Rd Ste 300, Virginia Beach, VA 23454 Phone: 757-395-1760 Fax: 757-756-5148 |